Mental illness stigma after a decade of Time to Change England: inequalities as targets for further improvement.

European Journal of Public Health
Claire HendersonEmily J Robinson

Abstract

England's Time to Change programme to reduce mental health-related stigma and discrimination included a social marketing campaign using traditional and social media, and targeted middle-income groups aged 25-45 between 2009 and 2016. From 2017, the same age group on low to middle incomes were targeted, and the content focused on men's mental health, by changing the advertising and adapting the 'key messages'. This study investigates changes in stigma-related public knowledge, attitudes and desire for social distance in England since Time to Change began in 2008-19 and for 2017-19. Using data from a face-to-face survey of a nationally representative quota sample of adults for England, we evaluated longitudinal trends in outcomes with regression analyses and made assumptions based on a simple random sample. The pre-existing survey used a measure of attitudes; measures of knowledge and desire for social distance were added in 2009. Reported in standard deviation units (95% CI), the improvement for knowledge for 2009-19 was 0.25 (0.19, 0.32); for attitudes, 2008-19, 0.32 (0.26, 0.39) and for desire for social distance, 2009-19 0.29 (0.23, 0.36). Significant interactions between year and both region and age suggest greater improveme...Continue Reading

References

Jan 1, 1981·Schizophrenia Bulletin·S M Taylor, M J Dear
Jun 2, 2006·Journal of Personality and Social Psychology·Thomas F Pettigrew, Linda R Tropp
Mar 3, 2009·The British Journal of Psychiatry : the Journal of Mental Science·Nisha MehtaGraham Thornicroft
Jun 9, 2009·Lancet·Claire Henderson, Graham Thornicroft
Aug 14, 2010·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Sara Evans-LackoGraham Thornicroft
May 18, 2011·Journal of Mental Health·Sarah ClementGraham Thornicroft
May 20, 2011·The British Journal of Psychiatry : the Journal of Mental Science·Kristian WahlbeckThomas Munk Laursen
Jan 17, 2012·Acta Psychiatrica Scandinavica·G SchomerusM C Angermeyer
Mar 16, 2013·American Journal of Public Health·Mark L HatzenbuehlerBruce G Link
Apr 12, 2013·The British Journal of Psychiatry. Supplement·Sara Evans-LackoGraham Thornicroft
Sep 12, 2014·Social Psychiatry and Psychiatric Epidemiology·Tarik QassemSimon Dein
May 1, 2011·Group Processes & Intergroup Relations : GPIR·Keon WestMiles Hewstone
Mar 16, 2016·Psychiatric Services : a Journal of the American Psychiatric Association·Edwin Ho-Ming LeeEric Yu-Hai Chen
Jun 10, 2016·Emerging Themes in Epidemiology·Odile SauzetJanet L Peacock
Jul 19, 2016·Acta Psychiatrica Scandinavica·C HendersonL Hansson
Dec 21, 2016·European Psychiatry : the Journal of the Association of European Psychiatrists·G SampognaC Henderson
Dec 21, 2018·Psychological Medicine·Emily J Robinson, Claire Henderson
May 6, 2019·Social Psychiatry and Psychiatric Epidemiology·Elizabeth IngramClaire Henderson

❮ Previous
Next ❯

Citations

Nov 6, 2020·Epidemiology and Psychiatric Sciences·R HildersleyC Henderson
Jan 20, 2021·International Journal of Mental Health Systems·Amy J MorganNicola J Reavley
Jan 23, 2021·Social Psychiatry and Psychiatric Epidemiology·Yan LiClaire Henderson
Jan 26, 2021·Frontiers in Public Health·Daniel Alexander Benjamin Walsh, Juliet Louise Hallam Foster
Feb 2, 2022·Journal of Mental Health·Susannah HermaszewskaJacqueline Sin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.